Related Experiment Video
Updated: Jul 15, 2026

06:07
Isolation and Culture of Primary Cochlear Hair Cells from Neonatal Mice
Published on: September 15, 2023
Orphan glutamate receptor delta1 subunit required for high-frequency hearing
Jiangang Gao1, Stéphane F Maison, Xudong Wu
1Department of Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, TN 38105, USA.
Molecular and Cellular Biology
|April 18, 2007
Summary
The orphan glutamate receptor delta 1 (GluRdelta1) is crucial for high-frequency hearing. Its absence causes hearing loss and ionic imbalance in the cochlea, suggesting it as a candidate gene for hearing impairment.
Area of Science:
- Neuroscience
- Otolaryngology
- Genetics
Background:
- The function of orphan glutamate receptor delta subunits (GluRdelta1 and GluRdelta2) is largely unknown.
- GluRdelta1 is expressed in inner ear hair cells and hippocampal neurons, while GluRdelta2 is specific to cerebellar Purkinje cells.
Purpose of the Study:
- To investigate the role of the orphan GluRdelta1 in auditory function and cochlear homeostasis.
- To determine if GluRdelta1 is a candidate gene for human hearing loss.
Main Methods:
- Analysis of mice genetically engineered to lack the GluRdelta1 protein.
- Assessment of auditory brainstem responses to evaluate hearing thresholds.
- Histological examination of cochlear structures, including spiral ligament fibrocytes.
- Measurement of the endolymphatic potential in high-frequency cochlear regions.
Main Results:
- Mice lacking GluRdelta1 exhibited significant threshold shifts for high-frequency hearing (>16 kHz).
- These mice showed a loss of type IV spiral ligament fibrocytes and reduced endolymphatic potential in basal cochlear regions.
- Acoustic injury vulnerability was increased, but efferent innervation and inhibition remained unaffected.
- Hippocampal and vestibular function were normal.
Conclusions:
- The orphan GluRdelta1 is essential for high-frequency hearing and maintaining ionic homeostasis in the basal cochlea.
- The gene encoding GluRdelta1 is a potential candidate for congenital and acquired high-frequency hearing loss in humans.

